Acute KRAS silencing in KRAS‐mutant pancreatic cancer cells by RNAi or CRISPR caused cell cycle arrest, apoptosis, and reduction of anchorage‐independent proliferation in vitro, as well as reduced tumour growth and metastasis in xenograft models. This evidence concerns the gene KRAS and familial pancreatic carcinoma.